Epiontis GmbH
Records under this name other than the patents Epiontis GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,876,163 | Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene Formerly held In force · High confidence | In force | High confidence | |
| US 12,286,675 | Epigenetic markers for the identification of blood sub-cells of type 1 Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,590,475 | Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1 Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,273,545 | Epigenetic Method for the Identification of Subpopulations of CD8+ T Lymphocytes, in Particular CD8 Alpha and Beta T Lymphocytes Formerly held In force · High confidence | In force | High confidence | |
| US 10,781,492 | Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,208,346 | Method for identifying the quantitative cellular composition in a biological sample Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,894,984 | Method for identifying the quantitative cellular composition in a biological sample Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,643,687 | LRP5 as Epigenetic Marker for the Identification of Immune Cells, in Particular B-Cells Formerly held In force · High confidence | In force | High confidence | |
| US 11,761,041 | PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,788,141 | MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells Formerly held In force · USPTO record | In force | USPTO record |